MarketPulse

polycythemia vera

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Polycythemia Vera Market Poised for Major Expansion as Nine Pharma Giants Rush New Therapies

Polycythemia vera market expected to expand 8.9% CAGR through 2036 from $2B base as nine pharma companies advance novel therapies, with rusfertide entering first.
MRKPTGXIRONTAKIONS+1clinical trialsmarket expansion
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Pegasys Market Poised for Growth Despite DAA Competition and Tariff Headwinds

Pegasys market projected for growth via rising hepatitis B prevalence and indication expansion, though direct-acting antivirals and tariff pressures pose challenges. Asia-Pacific represents fastest-growing region.
PFERHHBYGRFSemerging marketsoncology